Trial shows costs savings associated with use of Medtronic’s cryoballoon

Katherine Davis | | Cardiovascular Business | Economics

A new study assessing Medtronic’s cryoballoon catheter ablation device found significant cost savings as opposed to radiofrequency ablation, commonly used by cardiologists.

The FIRE AND ICE study was published Aug. 1 in the Journal of the American Heart Association. The data was originally presented at the 2016 Asia Pacific Heart Rhythm Society’s Scientific Sessions in Seoul, South Korea, according to a press release.

Patients in the study were randomly assigned to be treated with the cryoballoon or radio frequency. Results showed that when patients were treated with the cryoballoon, there were fewer repeats ablations and cardiovascular rehospitalizations.

"These findings show that patients treated with the cryoballoon have positive clinical outcomes such as fewer rehospitalizations and ablations, leading to decreased burden on health systems and lower costs," said Karl-Heinz Kuck, MD, the lead author on the study and the director of cardiology at Asklepios Klinik St. Georg in Hamburg, Germany, in a statement. "The latest analysis further validates cryoablation as an effective treatment option for atrial fibrillation patients with real economic value across health systems."

The cost savings were consistent across Germany, the United Kingdom and the United States—the three countries where the study was conducted.

"This analysis illustrates the Medtronic cryoballoon's sustained economic impact across multiple healthcare systems—improving patient outcomes with reduced healthcare utilization and lowering healthcare system costs," said Colleen Fowler, vice president and general manager of the AF Solutions business, part of the Cardiac and Vascular Group at Medtronic.

Katherine Davis,

Senior Writer

As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.

Related Content

Medical malpractice lawsuits are rare in sports cardiology—but they can cost providers millions
PFA market heats up as medtech companies announce new investments
Private equity firm jumps into vascular health with new investment
Female heart surgeons take home much lower salaries
Johnson & Johnson MedTech faces threat of permanent injunction after losing antitrust case
Atraverse Medical raises $29M to support FDA-approved heart tech

Around the web

Health Exec
Major association of physicians presents itself as a go-to alternative vs. the government on vaccine expertise

One of the most formidable societies of medical professionals in the U.S. is going toe-to-toe with Robert F. Kennedy’s HHS over changing vaccination recommendations. 

Health Exec
Tom Price: Medical residency slots need to expand to combat physician shortages

Tom Price, MD, former secretary of Health and Human Services (HHS), said one way to address the growing shortage of physicians is to expand medical resident positions, but these are tied to Medicare spending so alternative means may be needed.

Health Imaging
Tariffs will have a significant impact on the nuclear imaging supply chain in the US

"Domestic radiopharmaceutical suppliers, who receive isotopes from abroad, would be impacted by price changes and uncertainty caused by additional tariffs,” SNMMI President Cathy Cutler, PhD, wrote in a letter to the U.S. Department of Commerce this week.